Discover the Untapped Potential of the Rare Disease Market in the Middle East - Becoya

Who We Are
What We Do
- - - What We Do
    - We bridge science, strategy, and regional insight to help life sciences companies make confident, evidence-led commercial decisions.
- - - Offerings
    - Comprehensive advisory and partnership services shaping performance across every stage of the commercialisation journey.
    - Insights
    - Value & Access
    - Health Economics
    - Alliance
  - - Tools
    - Purpose-built platforms that transform data into clarity, foresight, and measurable advantage.
    - Pulse by Becoya
    - Vector by Becoya
    - Compass by Becoya
  - - Market Research Study to Understand the P&R Landscape for a New CAR-T Product in KSA
    - Read More
Case Studies
The Local Lens
Book A Meeting

White Paper

Discover the Untapped Potential of the Rare Disease Market in the Middle East

Read time: 6 mins

As one of the most attractive and lucrative markets in the Middle East, Saudi Arabia brings a strong opportunity for pharmaceutical and biotech manufacturers to obtain high prices and uptake within the GCC region, where price referencing against Saudi Arabia is key.

To continue reading and gain complete access,
please submit your details below.

March 2022

Share this article

Related White Papers

February 2026

Perception of Value of Breakthrough Designation in Saudi Arabia

Read More

August 2024

Rare Disease Funding: A Spotlight on Saudi Arabia

Read More

November 2025

The Localization Imperative: Navigating the New Localization Requirements in Saudi Arabia

Read More

Share this link via

link